SCHEMBL3361285

SCHEMBL3361285

CS(=O)(=O)NC(=O)N(C(=O)NS(C)(=O)=O)C1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 13/20 0.65
DRD3 P35462 12/20 0.65
HTR1A P08908 2/20 0.65
ADRA2A P08913 2/20 0.65
DRD4 P21917 2/20 0.65
HTR2A P28223 2/20 0.65
HTR2C P28335 2/20 0.65
HTR7 P34969 2/20 0.65
ADRA1A P35348 2/20 0.65
HRH1 P35367 2/20 0.65
ABCB11 O95342 1/20 0.65
CHRM2 P08172 1/20 0.65
CHRM1 P11229 1/20 0.65
DRD1 P21728 1/20 0.65
DRD5 P21918 1/20 0.65
HTR2B P41595 1/20 0.65
KCNH2 Q12809 1/20 0.65
CHRM4 P08173 1/20 0.64
ADRB1 P08588 1/20 0.64
CHRM5 P08912 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1774667 0.91 DRD2 (0.66) DRD2DRD3HTR1AADRA2ADRD4
SCHEMBL184341 0.89 DRD2 (0.71) DRD2DRD3HTR1AADRA2ADRD4
Bromide SCHEMBL1775020 0.88 DRD2 (0.69) DRD2DRD3HTR1AADRA2ADRD4
Hydrochloric Acid SCHEMBL183841 0.88 DRD2 (0.70) DRD2DRD3HTR1AADRA2ADRD4
Hydrochloric Acid SCHEMBL1774393 0.88 DRD2 (0.70) DRD2DRD3HTR1AADRA2ADRD4
SCHEMBL29544737 0.85 DRD2 (0.68) DRD2DRD3HTR1AADRA2ADRD4
Maleic Acid SCHEMBL1774461 0.84 DRD2 (0.64) DRD2DRD3HTR1AADRA2ADRD4
SCHEMBL29282392 0.82 DRD2 (0.64) DRD2DRD3HTR1AADRA2ADRD4
SCHEMBL3674514 0.82 DRD2 (0.71) DRD2DRD3HTR1AADRA2ADRD4
SCHEMBL18041270 0.82 DRD2 (0.71) DRD2DRD3HTR1AADRA2ADRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137335-A1 METABOLITES OF (THIO) CARBAMOYL-CYCLOHEXANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2010-06-03 US disclosed
EP-2155707-A1 METABOLITES OF (THIO)CARBAMOYL-CYCLOHEXANE DERIVATIVES Richter Gedeon NYRT (HU) 2010-02-24 EP disclosed
WO-2008142461-A1 METABOLITES OF (THIO)CARBAMOYL-CYCLOHEXANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2008-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137335-A1 METABOLITES OF (THIO) CARBAMOYL-CYCLOHEXANE DERIVATIVES TACR2, TACR1, CNR2 DRD2 10/4885DRD3 37/4885HTR1A 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.